Fixed Price IPO | ₹15 Cr | Listed at BSE | Tue, Sep 25, 2007 - Fri, Sep 28, 2007
Saamya Biotech IPO is a fixed price issue of ₹15.01 crores. The issue is entirely a fresh issue of 1.50 crore shares of ₹15.01 crore.
Saamya Biotech IPO bidding started from Sep 25, 2007 and ended on Sep 28, 2007. The shares got listed on BSE on Oct 19, 2007.
Saamya Biotech IPO price is ₹10 per share. The lot size for an application is 500. The minimum amount of investment required by an individual investor (retail) is ₹5,000 (500 shares) (based on upper price). The lot size investment for sNII is 41 lots (20,500 shares), amounting to ₹2,05,000, and for bNII, it is 201 lots (1,00,500 shares), amounting to ₹10,05,000.
UTI Securities Ltd. is the book running lead manager and Aarthi Consultants Pvt.Ltd. is the registrar of the issue.
Refer to Saamya Biotech IPO RHP for detailed Information.
IPO Open
Tue, Sep 25, 2007
IPO Close
Fri, Sep 28, 2007
Issue Price
₹10 per share
Market Cap (Pre-IPO)
₹23.08 Cr
| IPO Date | 25 to 28 Sep, 2007 |
| Listed on | Fri, Oct 19, 2007 |
| Face Value | ₹10 per share |
| Issue Price | ₹10 per share |
| Lot Size | 500 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE |
| Total Issue Size | 1,50,12,500 shares (agg. up to ₹15 Cr) |
| Fresh Issue | 1,50,12,500 shares (agg. up to ₹15 Cr) |
| Share Holding Pre Issue | 80,80,000 shares |
| Share Holding Post Issue | 2,30,80,000 shares |
| BSE Script Code | 532905 |
| ISIN | INE320H01019 |
Saamya Biotech IPO comprises a total issue size of 1,50,00,000 shares. Out of which, 15,00,000 (10.00%) are allocated to QIB, 67,50,000 (45.00%) allocated to NII 67,50,000 (45.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 15,00,000 | 10.00% | NA |
| NII (HNI) Shares Offered | 67,50,000 | 45.00% | NA |
| Retail Shares Offered | 67,50,000 | 45.00% | 13,500 |
| Total Shares Offered | 1,50,00,000 | 100.00% |
Investors can bid for a minimum of 500 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 500 | ₹5,000 |
| Retail (Max) | 40 | 20,000 | ₹2,00,000 |
| S-HNI (Min) | 41 | 20,500 | ₹2,05,000 |
Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad-based Biotech company. SBIL manufactures and markets bio-pharmaceutical and recombinant protein products to medical and other industries.
SBIL proposes to set up world-class facilities for the manufacture of fermentation-based high-value Biotech Products. SBIL embarks on developing effective strategies for the production and supply of both bulk and formulations with special focus on life-saving drug entities at an affordable price.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Land and site development | 0.08 |
| 2 | Buildings & Civil Works | 0.32 |
| 3 | Plant and machinery | 1.22 |
| 4 | Technical know-how fee | 0.50 |
| 5 | Misc. fixed assets | 0.05 |
| 6 | Preliminary and Pre-operative expenses | 0.40 |
| 7 | Contingencies | 0.14 |
| 8 | Margin money for working capital | 0.01 |
| Total | 2.72 |
Sorry, we couldn't find the subscription details. Note that the bidding starts at 10 AM and ends at 5 PM on the days when the public issue is open.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | fees payable to the Lead Manager, | |
| 2 | fees payable to the Registrars to the Issue | |
| 3 | fees of Legal Advisors | |
| 4 | Stamp Duty, Printing, Publication, Advertising and Distribution expense | |
| 5 | Bank charges | |
| 6 | Listing Fees | |
| 7 | Brokerage and other Miscellaneous Expense |
| Price Details | BSE |
|---|---|
| Final Issue Price | ₹10.00 |
| Open | ₹17.50 |
| Low | ₹13.85 |
| High | ₹24.35 |
| Last Trade | ₹15.30 |
Lead Manager Reports
Saamya Biotech IPO is a main-board IPO of 1,50,12,500 equity shares of the face value of ₹10 aggregating up to ₹15 Crores. The issue is priced at ₹10 per share. The minimum order quantity is 500.
The IPO opens on Tue, Sep 25, 2007, and closes on Fri, Sep 28, 2007.
Aarthi Consultants Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE.
Zerodha customers can apply online in Saamya Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Saamya Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Saamya Biotech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Saamya Biotech IPO opens on Tue, Sep 25, 2007 and closes on Fri, Sep 28, 2007.
Saamya Biotech IPO lot size is 500, and the minimum amount required for application is ₹5,000.
You can apply in Saamya Biotech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Saamya Biotech IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Saamya Biotech IPO allotment status.
The Saamya Biotech IPO listing date is on Fri, Oct 19, 2007.
